Informing selection of drugs for COVID-19 treatment through adverse events analysis

Código QR

Informing selection of drugs for COVID-19 treatment through adverse events analysis

Abstract Coronavirus disease 2019 (COVID-19) is an ongoing pandemic and there is an urgent need for safe and effective drugs for COVID-19 treatment. Since developing a new drug is time consuming, many approved or investigational drugs have been repurposed for COVID-19 treatment in clinical trials. T...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Wenjing Guo, Bohu Pan, Sugunadevi Sakkiah, Zuowei Ji, Gokhan Yavas, Yanhui Lu, Takashi E. Komatsu, Madhu Lal-Nag, Weida Tong, Tucker A. Patterson, Huixiao Hong
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2021
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/cec1715e9fd24f53a1ff4e77983d08f9
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Evaluation of the Direct Costs of Managing Adverse Drug Events in all Ages and of Avoidable Adverse Drug Events in Older Adults in Japan
por: Hayato Katsuno, et al.
Publicado: (2021)

Adverse Events Related to Off-Label Drugs Using Spontaneous Adverse Event Reporting Systems
por: Han N, et al.
Publicado: (2021)

A Deep Learning-Based Text Classification of Adverse Nursing Events
por: Wenjing Lu, et al.
Publicado: (2021)

Assessment and monitoring of biologic drug adverse events in patients with psoriasis
por: Hanley T, et al.
Publicado: (2016)

Common Immune-Related Adverse Events of Immune Checkpoint Inhibitors in the Gastrointestinal System: A Study Based on the US Food and Drug Administration Adverse Event Reporting System
por: Xiaoyin Bai, et al.
Publicado: (2021)

RISK FACTORS FOR EARLY PREDICTION OF ADVERSE DRUG EVENTS RELATED TO HOSPITALIZATIONS
por: Patricia de Carvalho Mastroianni, et al.

Risk factors for early prediction of adverse drug events related to hospitalizations
por: Patricia de Carvalho MASTROIANNI, et al.
Publicado: (2016)

Pulmonary adverse drug event data in hypertension with implications on COVID-19 morbidity
por: Majid Jaberi-Douraki, et al.
Publicado: (2021)

Travelers’ vaccines and their adverse events in Nara, Japan
por: Ogawa Taku, et al.
Publicado: (2021)

Exploration of virtual candidates for human HMG-CoA reductase inhibitors using pharmacophore modeling and molecular dynamics simulations.
por: Minky Son, et al.
Publicado: (2013)

The Mediating Processes between Depression and Cardiac Adverse Events
por: R Bagherian,, et al.
Publicado: (2011)

Analysis of chemotherapy-induced peripheral neuropathy using the Japanese Adverse Drug Event Report database
por: Misaki Inoue, et al.
Publicado: (2021)

A population-based study of self-reported adverse drug events among Lebanese outpatients
por: Elsy Ramia, et al.
Publicado: (2021)

Adverse drug events: description of an active search process in a teaching hospital of the Sentinela Network
por: Wanessa S. NOGUEIRA, et al.
Publicado: (2021)

Torsadogenic risk of antipsychotics: combining adverse event reports with drug utilization data across Europe.
por: Emanuel Raschi, et al.
Publicado: (2013)

Multi-omics prediction of immune-related adverse events during checkpoint immunotherapy
por: Ying Jing, et al.
Publicado: (2020)

Systemic adverse events after screening of retinopathy of prematurity with mydriatic.
por: Shumpei Obata, et al.
Publicado: (2021)

Management of gastrointestinal adverse events induced by immune-checkpoint inhibitors
por: Zheng-Hang Wang, et al.
Publicado: (2018)

Correlative Analysis Between Adverse Events of Preoperative Chemotherapy and Postoperative Complications of Gastric Cancer
por: Zhouqiao Wu, et al.
Publicado: (2021)

Adverse drug events in older hospitalized patients: results and reliability of a comprehensive and structured identification strategy.
por: Joanna E Klopotowska, et al.
Publicado: (2013)

Drug-associated adverse events and their relationship with outcomes in patients receiving treatment for extensively drug-resistant tuberculosis in South Africa.
por: Karen Shean, et al.
Publicado: (2013)

Adverse drug events in Chinese pediatric inpatients and associated risk factors: a retrospective review using the Global Trigger Tool
por: Huan-huan Ji, et al.
Publicado: (2018)

Adverse events of inactivated COVID-19 vaccine in HIV-infected adults
por: Songjie Wu, et al.
Publicado: (2021)

Cutaneous Adverse Events of Immune Checkpoint Inhibitors: A Literature Review
por: Zoe Apalla, et al.
Publicado: (2021)

Attitudes toward metabolic adverse events among patients with schizophrenia in Japan
por: Sugawara N, et al.
Publicado: (2016)

Vigilancia de eventos adversos a vacunas: Adverse events surveillance
por: Abarca V,Katia
Publicado: (2007)

The benefits of modified FOLFIRINOX for advanced pancreatic cancer and its induced adverse events: a systematic review and meta-analysis
por: Hongxuan Tong, et al.
Publicado: (2018)

MIHARI project, a preceding study of MID-NET, adverse event detection database of Ministry Health of Japan-Validation study of the signal detection of adverse events of drugs using export data from EMR and medical claim data.
por: Hiroshi Watanabe, et al.
Publicado: (2021)

Adverse events after inactivated influenza vaccination among children less than 2 years of age: analysis of reports from the vaccine adverse event reporting system, 1990-2003
por: Delpiano M.,Luis
Publicado: (2005)

Adverse events of extracorporeal ultrasound-guided high intensity focused ultrasound therapy.
por: Tinghe Yu, et al.
Publicado: (2011)

Development of instrument to report and assess causality of adverse events related to herbal medicines
por: Patrícia de Carvalho Mastroianni, et al.

Immune-mediated adverse events in immune checkpoint inhibitors therapy: literature review
por: Marina A. Lyadova, et al.
Publicado: (2021)

Analysis of characteristics and predictive factors of immune checkpoint inhibitor-related adverse events
por: Rilan Bai, et al.
Publicado: (2021)

Early adverse events, HPA activity and rostral anterior cingulate volume in MDD.
por: Michael T Treadway, et al.
Publicado: (2009)

Development of instrument to report and asses causality of adverse events related to herbal medicines
por: Patricia de Carvalho MASTROIANNI, et al.
Publicado: (2017)

Monitoring and Managing BTK Inhibitor Treatment-Related Adverse Events in Clinical Practice
por: Susan M. O’Brien, et al.
Publicado: (2021)

Adverse drug reactions
por: AA Moghadam Nia
Publicado: (1999)

Ontology-based systematical representation and drug class effect analysis of package insert-reported adverse events associated with cardiovascular drugs used in China
por: Liwei Wang, et al.
Publicado: (2017)

Potential adverse drug events and its predictors among hospitalized patients at medical center in Ethiopia: a prospective observational study
por: Tamiru Sahilu, et al.
Publicado: (2021)

Assessment of pancreatitis associated with tocilizumab use using the United States Food and Drug Administration Adverse Event Reporting System database
por: Ashwin Kamath, et al.
Publicado: (2021)